Dialyspa The Woodlands in Oak Ridge, Texas - Dialysis Center

Dialyspa The Woodlands is a medicare approved dialysis facility center in Oak Ridge, Texas and it has 18 dialysis stations. It is located in Montgomery county at 27172 I-45 North, Oak Ridge, TX, 77385. You can reach out to the office of Dialyspa The Woodlands at (713) 218-6500. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Dialyspa The Woodlands has the following ownership type - Profit. It was first certified by medicare in November, 2015. The medicare id for this facility is 672765 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameDialyspa The Woodlands
Location27172 I-45 North, Oak Ridge, Texas
No. of Dialysis Stations 18
Medicare ID672765
Managed ByIndependent
Ownership TypeProfit
Late Shifts No

Contact Information


27172 I-45 North, Oak Ridge, Texas, 77385
(713) 218-6500

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Dialyspa The Woodlands from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1336406362
Organization NameDialyspa The Woodlands
Doing Business AsDialyspa Iii, Llc
Address27172 I 45 N Oak Ridge North, Texas, 77385
Phone Number(713) 218-6500

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data27
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL4
Medicare patients who had average hemoglobin (hgb) greater than 12 g/dL4

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center45
    Adult patient months included in Kt/V greater than or equal to 1.2440
    Percentage of adult patients getting regular hemodialysis at the center98
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

    With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

    WHO says bird flu cluster shows no evidence of virus mutating

    The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

    Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

    According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

    Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

    Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

    Read more Medical News

    › Verified 5 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center8
    Adult patient months included in Kt/V greater than or equal to 1.765
    Percentage of adult patients getting regular peritoneal dialysis at the center
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

    With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

    WHO says bird flu cluster shows no evidence of virus mutating

    The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

    Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

    According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

    Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

    Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

    Read more Medical News

    › Verified 5 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Dialyspa The Woodlands with elevated calcium levels.

Patients with hypercalcemia55
Hypercalcemia patient months526
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor57
Patients with Serumphosphor less than 3.5 mg/dL4
Patients with Serumphosphor from 3.5 to 4.5 mg/dL20
Patients with Serumphosphor from 4.6 to 5.5 mg/dL45
Patients with Serumphosphor from 5.6 to 7 mg/dL17
Patients with Serumphosphor greater than 7 mg/dL14

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 38
Patient months included in arterial venous fistula and catheter summaries 315
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment74
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer7

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary30
Hospitalization Rate in facility127.6 (As Expected)
Hospitalization Rate: Upper Confidence Limit348.5
Hospitalization Rate: Lower Confidence Limit50.6

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Dialyspa The Woodlands were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility24.2 (As Expected)
Readmission Rate: Upper Confidence Limit51.6
Readmission Rate: Lower Confidence Limit7.6

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Dialyspa The Woodlands get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.98 (As Expected)
SIR: Upper Confidence Limit4.38
SIR: Lower Confidence Limit.72

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Dialyspa The Woodlands's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 12
Transfusion Rate in facility (Not Available)
Transfusion Rate: Upper Confidence Limit
Transfusion Rate: Lower Confidence Limit

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Dialyspa The Woodlands lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary123
Mortality Rate in facility11.1 (As Expected)
Mortality Rate: Upper Confidence Limit24.1
Mortality Rate: Lower Confidence Limit4.1

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago


Dialysis Facility in Oak Ridge, TX

Dialyspa The Woodlands
Location: 27172 I-45 North, Oak Ridge, Texas, 77385
Phone: (713) 218-6500

News Archive

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

WHO says bird flu cluster shows no evidence of virus mutating

The World Health Organisation (WHO) has confirmed that a 32-year-old Indonesian man from Sumatra died on May 22 from the H5N1 strain of bird flu.

Faith-based organizations play a major role in HIV/AIDS care in Zambia and Lesotho

According to an important study released today by the World Health Organization (WHO) at the National Cathedral in Washington DC, efforts are needed to encourage greater collaboration between public health agencies and faith-based organizations (FBOs), if progress is to be made towards the goal of universal access towards HIV prevention, treatment, care and support by 2010.

Synthetic Biologics' SYN-005 antibody gets FDA Orphan Drug designation for Pertussis treatment

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that the U.S. Food and Drug Administration has granted Orphan Drug designation to the Company's proprietary SYN-005 monoclonal antibody (mAb) combination for the treatment of Pertussis, more commonly known as whooping cough.

Read more Medical News

› Verified 5 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.